NOVEL POLYMORPH V OF TORASEMIDE

The invention relates to a novel polymorph V of torasemide, to a process for its preparation, to its use as a raw material for the preparation of crystalline modifications I and III of torasemide, to amorphous torasemide modifications and to pharmaceutically acceptable salts of torasemide, to pharma...

Full description

Saved in:
Bibliographic Details
Main Authors DUMI&CACUTE, DANILOVSKI, ALEKSANDAR, KLEPI&CCARON, TUDJA, MARIJAN, FILI&CACUTE
Format Patent
LanguageEnglish
French
Published 22.11.2001
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to a novel polymorph V of torasemide, to a process for its preparation, to its use as a raw material for the preparation of crystalline modifications I and III of torasemide, to amorphous torasemide modifications and to pharmaceutically acceptable salts of torasemide, to pharmaceutical forms containing the said novel polymorph V of torasemide as the active ingredient as well as to its use. La présente invention concerne un nouveau polymorphe V de torasémide, un procédé pour son élaboration, son utilisation comme matière de départ pour l'élaboration des modifications cristallines I et III du tosasémide, des modifications de torasémide amorphe et des sels de torasémide pharmaceutiquement admis, des formes pharmaceutiques contenant ledit nouveau polymorphe V du torasémide intervenant comme principe actif, ainsi que son utilisation.
Bibliography:Application Number: WO2000HR00033